CAS 870087-36-8

Formule : C25H34N6O8S2

InChI : InChI=1S/C23H26N6O2.2CH4O3S/c1-18-5-4-6-19(15-18)17-25-28-21-16-22(29-10-13-30-14-11-29)27-23(26-21)31-12-8-20-7-2-3-9-24-20;2*1-5(2,3)4/h2-7,9,15-17H,8,10-14H2,1H3,(H,26,27,28);2*1H3,(H,2,3,4)/b25-17+;;

Code InChI : GAJWNIKZLYZYSY-OKUPSQOASA-N

SMILES : CC1=CC(=CC=C1)/C=N/NC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4.CS(=O)(=O)O.CS(=O)(=O)O

Benzaldehyde, 3-methyl-,[6-(4-morpholinyl)-2-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl]hydrazone,dimethanesulfonate

CAS : 870087-36-8

Formule : C₂₅H₃₄N₆O₈S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 610.7029

Ref: IN-DA00IEBC

4-(6-(2-(3-Methylbenzylidene)Hydrazinyl)-2-(2-(Pyridin-2-Yl)Ethoxy)Pyrimidin-4-Yl)Morpholine Dimethanesulfonate

CAS : 870087-36-8

4-(6-(2-(3-Methylbenzylidene)Hydrazinyl)-2-(2-(Pyridin-2-Yl)Ethoxy)Pyrimidin-4-Yl)Morpholine Dimethanesulfonate

Formule : C₂₅H₃₄N₆O₈S₂

Degré de pureté : 98%

Masse moléculaire : 610.7

Ref: 54-OR1023246

Apilimod mesylate

CAS : 870087-36-8

Apilimod mesylate

Formule : C₂₅H₃₄N₆O₈S₂

Degré de pureté : ≥95%

Masse moléculaire : 610.7

Ref: 54-BUP14513

Apilimod mesylate

CAS : 870087-36-8

4-(6-(2-(3-Methylbenzylidene)hydrazinyl)-2-(2-(pyridin-2-yl)ethoxy)pyrimidin-4-yl)morpholine dimethanesulfonate

Formule : C₂₅H₃₄N₆O₈S₂

Degré de pureté : 98%

Masse moléculaire : 610.7

Ref: IN-DG449971

Apilimod mesylate

CAS : 870087-36-8

Apilimod mesylate (STA 5326 mesylate) is a potent IL-12/IL-23 inhibitor.

Formule : C₂₅H₃₄N₆O₈S₂

Degré de pureté : 99.51% - ≥95%

Couleur et forme : White Solid

Masse moléculaire : 610.7

Ref: TM-T3533

APILIMOD MESYLATE

CAS : 870087-36-8

Degré de pureté : 98%

Masse moléculaire : 610.7000122

Ref: 10-F801839

Apilimod mesylate

CAS : 870087-36-8

Apilimod mesylate is a small molecule that inhibits viral replication by selective inhibition of the toll-like receptor (TLR) signaling pathway. Apilimod mesylate has been shown to have significant cytotoxicity in vitro and in vivo. It also has the ability to inhibit both TLR-3 and TLR-4, which are receptors for the recognition of lipopolysaccharide, an inflammatory molecule produced by Gram-negative bacteria. Apilimod mesylate has been shown to be effective in treating bowel disease and eye disorders such as dry eye. Apilimod mesylate has a long half-life and provides significant efficacy following long term treatment with no observed toxicity.

Degré de pureté : Min. 95%

Ref: 3D-BA177431